Literature DB >> 8827767

Changes in endothelial cell and smooth muscle cell integrin expression during closure of the ductus arteriosus: an immunohistochemical comparison of the fetal, preterm newborn, and full-term newborn rhesus monkey ductus.

R I Clyman1, B W Goetzman, Y Q Chen, F Mauray, R H Kramer, R Pytela, L M Schnapp.   

Abstract

Anatomical closure of the ductus arteriosus requires normally quiescent luminal endothelial cells and medial smooth muscle cells to migrate into the subendothelial space forming intimal mounds that eventually coalesce and occlude the vessel's lumen. The migration of endothelial cells and smooth muscle cells requires the presence of integrin receptors that interact with the surrounding matrix. We used immunohistochemical staining to examine the repertoires of integrins expressed by endothelial cells and smooth muscle cells during postnatal closure of the ductus arteriosus in full-term and preterm rhesus monkeys. In the fetal ductus, luminal endothelial cells have a limited repertoire of integrins. During postnatal ductus closure, luminal endothelial cells, of both term and preterm monkeys, change their phenotype and express the full repertoire of integrins found on growing capillary endothelial cells (alpha 1 beta 1, alpha 2 beta 1, alpha 3 beta 1, alpha 6 beta 1, alpha v beta 1, alpha 6 beta 4, and alpha v beta 5). Similarly, during ductus closure, smooth muscle cells of both term and preterm monkeys expand their integrin repertoire to include the alpha 5 beta 1 and alpha v beta 3 integrins; these two integrins have been shown to be essential for smooth muscle cell migration in vitro. These changes in integrin profile occur at the same time the endothelial and smooth muscle cells invade their neighboring compartments. In contrast, preterm monkeys with a persistently patent ductus lumen fail to develop these changes in integrin expression and fail to develop neointimal mounds. No evidence of intimal thickening occurs in the absence of changes in integrin expression. Therefore, endothelial cells and smooth muscle cells change phenotypes to produce the intimal thickening required for ductus closure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827767     DOI: 10.1203/00006450-199608000-00004

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

Review 1.  Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis.

Authors:  S M Schwartz
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

2.  Transcriptional profiling reveals ductus arteriosus-specific genes that regulate vascular tone.

Authors:  Elaine L Shelton; Gerren Ector; Cristi L Galindo; Christopher W Hooper; Naoko Brown; Irene Wilkerson; Elise R Pfaltzgraff; Bibhash C Paria; Robert B Cotton; Jason Z Stoller; Jeff Reese
Journal:  Physiol Genomics       Date:  2014-05-01       Impact factor: 3.107

3.  alpha5beta1 integrin expression and luminal edge fibronectin matrix assembly by smooth muscle cells after arterial injury.

Authors:  J G Pickering; L H Chow; S Li; K A Rogers; E F Rocnik; R Zhong; B M Chan
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

4.  Anatomic closure of the premature patent ductus arteriosus: The role of CD14+/CD163+ mononuclear cells and VEGF in neointimal mound formation.

Authors:  Nahid Waleh; Steven Seidner; Donald McCurnin; Luis Giavedoni; Vida Hodara; Susan Goelz; Bao Mei Liu; Christine Roman; Ronald I Clyman
Journal:  Pediatr Res       Date:  2011-10       Impact factor: 3.756

5.  Yap/Taz transcriptional activity is essential for vascular regression via Ctgf expression and actin polymerization.

Authors:  Ayumi Nagasawa-Masuda; Kenta Terai
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

Review 6.  Molecular Mechanisms for Regulating Postnatal Ductus Arteriosus Closure.

Authors:  Yu-Chi Hung; Jwu-Lai Yeh; Jong-Hau Hsu
Journal:  Int J Mol Sci       Date:  2018-06-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.